Dilated Cardiomyopathy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Reverse Remodelling and Remission Markers in the Serial Evaluation of Recent-onset Dilated Cardiomyopathy
Condition: Dilated Cardiomyopathy Intervention: Other: 12 months of guideline-directed heart failure therapy Sponsors: Imperial College London; Royal Brompton & Harefield NHS Foundation Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 12, 2021 Category: Research Source Type: clinical trials
Zinc Deficiency in Dilated Cardiomyopathy
Condition: Zinc Deficiency Intervention: Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 27, 2021 Category: Research Source Type: clinical trials